AFTER seven long years, IHH Healthcare Bhd
has finally received the long-awaited green light to proceed with its mandatory open offer for an additional 26% stake in India’s Fortis Healthcare and its subsidiary, Malar Hospitals.
The approval from India’s market regulator marks a major turning point in one of Asia’s most protracted cross-border healthcare sagas – one that has spanned courtrooms, boardrooms, and even shifts in corporate leadership.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
